Introduction
Human respiratory syncytial virus (HRSV) is a major cause of lower respiratory tract disease in babies and vulnerable adults (review by Collins et al., 1996) . A characteristic feature of HRSV is that moderate levels of antibody do not provide lasting protection, although prior infection can modulate the severity of the disease. HSRV is classified in the genus Pneumovirus, subfamily Pneumovirinae, family Paramyxoviridae. Other members of this genus include RSV of cattle, goats and sheep, and pneumonia virus of mice (PVM). The avian pneumovirus (APV) turkey rhinotracheitis virus differs significantly in terms of gene order and number (Pringle & Easton, 1997) and has been designated as a second genus of the subfamily Pneumovirinae (Pringle, 1996) .
All pneumoviruses encode two major surface glycoproteins (G and F) which are incorporated in the virus particle : the attachment (G) protein, which binds the virus to the cell receptor, and the F protein, which mediates fusion of cell and viral membranes. Antibodies directed against either G or F protein neutralize virus infectivity and seem to play a major role in protective immunity against HRSV (Hall et al., 1991) . In experimental animal models the F protein induces a broadly cross-reactive and protective antibody response, whereas the G protein induces neutralizing antibodies that protect only against viruses of the same antigenic group (Olmsted et al., 1986 ; Stott et al., 1987) .
Vaccinia recombinants that express either HRSV F or G protein induce different patterns of T helper (Th) immune response in BALB\c mice. Whereas the F protein induces preferentially a Th1 type immune response, the G protein induces mainly a Th2 response (Alwan & Openshaw, 1993 ; Graham et al., 1993) . The latter has been associated with the pulmonary eosinophilia found in mice immunized with G protein and challenged with HRSV (Alwan et al., 1993 ; Hancock et al., 1996) . This finding may be related to the enhanced pathology observed in children who received a formalin-inactivated vaccine during trials carried out in the 1960s (Kapikian et al., 1968) . This vaccine did not protect children from further HRSV infections despite induction of moderate levels of serum neutralizing antibodies and most children developed an exacerbated disease after natural infection. The enhanced pathology associated with the formalin-inactivated vaccine was probably related to a Th2 type immune response (Murphy et al., 1994 ; Hancock et al., 1996) .
The attachment glycoproteins of pneumoviruses share neither sequence nor structural features with the attachment proteins (HN or H) of other paramyxoviruses (reviewed by Collins et al., 1996) . In fact, the high serine, threonine and proline content of the HRSV G glycoprotein (Wertz et al., 1985) resembles the amino acid composition of mucins, a class of proteins produced and secreted by epithelial cells (review by Apostolopoulos & McKenzie, 1994) . The G proteins of RSV, PVM and APV show little homology but have similar overall amino acid content with a high proportion of serine, threonine and proline residues (Ling et al., 1992 ; Randhawa et al., 1995) .
The G protein is the most variable gene product between HRSV isolates, and antigenic differences detected with monoclonal antibodies specific for the G protein have been used to classify HRSV isolates into two groups (A and B) . Sequence identity at the amino acid level is only 53 % between the G proteins of the prototype strains of groups A and B (Johnson et al., 1987) , and up to 20 % sequence variation has been observed among the G proteins of HRSV isolates of the same antigenic group (Garcı! a et al., 1994) . Thus, the attachment protein of HRSV is a highly variable protein with unusual structural and immunological features. In this review, we evaluate the evidence that at least some of the variability observed in the G protein of HRSV isolates is a consequence of selection by the immune response. Fig. 1) . A soluble\secreted form of the G protein (Gs) (Hendricks et al., 1988) is generated by initiation of translation at an alternative in-frame AUG triplet located in the middle of the hydrophobic domain, followed by proteolytic removal of the signal\anchor domain (Roberts et al., 1994) .
(
The G molecule is synthesized as a 32 kDa polypeptide precursor which is extensively modified by the addition of both N-and O-linked oligosaccharides (Gruber & Levine, 1985) . The G protein is also palmitylated, probably at a single cysteine residue located in the N-terminal cytoplasmic tail (Collins & Mottet, 1992) . High mannose N-linked sugar chains are cotranslationally added to the G protein precursor to yield intermediate species of 45-50 kDa (Wertz et al., 1989 ; Collins & Mottet, 1992 ). This step is followed by the conversion of the N-linked sugars to the complex type and addition of O-linked sugars in the Golgi compartment to achieve the mature form of 80-90 kDa (estimated by SDS-PAGE). Virus infectivity is sensitive to limited removal of N-or O-linked oligosaccharides by endoglycosidases, indicating that carbohydrates are needed for G protein function (Lambert, 1988) . The formation of G protein homooligomers (most likely trimers) occurs at early stages of the maturation pathway, probably in the endoplasmic reticulum (Collins & Mottet, 1992) .
The C-terminal ectodomain of the G protein has a central region (amino acids 164-176) and four cysteines (residues 173, 176, 182 and 186) which are conserved in all HRSV isolates (Fig. 1 ). This region is slightly hydrophobic and has been proposed as the putative receptor binding site (Johnson et al., 1987) . Flanking this region, there are two protein segments which have a high level of sequence variation and a high serine and threonine content, potential sites for O-glycosylation. These variable regions have overall amino acid compositions similar to those of the mucins secreted by epithelial cells.
Antigenic structure
The most studied aspect of the immunity to HRSV G protein has been the analysis of the antibody response, since there is little evidence of a class I restricted cytotoxic T lymphocyte response to this protein in humans (Cherrie et al., 1992) .
Murine monoclonal antibodies
A large number of murine monoclonal antibodies have been raised against the G glycoprotein of HRSV and they have been used to classify viral isolates into two antigenic groups, A and B (Anderson et al., 1985 ; Mufson et al., 1985 ; Garcı! aBarreno et al., 1989) . By testing the reactivity of monoclonal antibodies with a large panel of viral strains, three types of epitope have been identified in the G protein : (i) conserved epitopes that are present in all the HRSV isolates, (ii) groupspecific epitopes shared by all viruses of the same antigenic group and (iii) strain-specific or variable epitopes that are present in certain isolates of the same antigenic group (Martı! nez et al., 1997) .
All the anti-G monoclonal antibodies obtained so far react with the mature form of the G molecule in Western blot assays and some react with synthetic peptides (Akerlind-Stopner et al., 1990 ; Garcı! a-Barreno et al., 1992) , suggesting that they recognize ' linear ' rather than ' conformational ' epitopes.
However, carbohydrates also contribute to the antigenic structure of the G molecule and certain antibodies either do not react with the unglycosylated G protein precursor (Palomo et al., 1991) or they depend on cell-type-specific glycosylation for recognition of the G molecule (Garcı! a-Beato et al., 1996) . Interestingly, the carbohydrate dependence for antibody recognition was only observed with certain variable epitopes located in protein regions of high serine\threonine content (Garcı! a-Beato et al., 1996) but not with conserved and groupspecific epitopes that are located in the central segment of the G protein ectodomain, and lack potential glycosylation sites (Fig. 1) .
The mapping of epitopes to the primary structure of HRSV G glycoprotein has been achieved mainly by sequencing escape mutants selected with individual monoclonal antibodies. Fig. 1 indicates the positions of amino acid residues that are essential for the integrity of certain epitopes. Antibodies that recognized conserved (c793 and 021\1G) and group Aspecific epitopes (021\19G and 021\18G) selected escape mutants with amino acid changes located in the central region of the G molecule (Rueda et al., 1994 ; Martı! nez et al., 1997) . In contrast, the antibodies that recognized strain-specific epitopes selected mutants with amino acid changes located in the Cterminal variable region of the G molecule, except antibody 021\5G which selected mutants with alterations in the other variable region preceding the cysteine cluster ( Fig. 1 ) (Garcı! a- Rueda et al., 1991 Rueda et al., , 1995 Martı! nez et al., 1997) . Thus, the conserved or variable character of the epitopes determined the position in the G protein primary structure of the amino acid changes selected with the corresponding antibodies. Certain antibodies (021\5G, 021\1G, 68G, 021\8G, 25G, 021\7G, 59G and 27G) selected mutants with amino acid substitutions in closely spaced residues of the G protein sequence, reinforcing the notion that they recognize ' linear ' epitopes. No antibody was capable of selecting mutations at distant residues of the G protein primary structure, indicating a lack of ' conformational ' epitopes.
Besides single amino acid substitutions, some escape mutants may have more dramatic changes : (i) frame shift mutations generated by deletions or insertions of single adenosine residues in viruses selected with antibody 63G -in the extreme situation the frame-shift changes altered the entire sequence of the C-terminal third of the G protein (Garcı! a- ; (ii) premature stop codons that shorten the length of the G protein by between 1 and 42 amino acids for the Long strain or 21 amino acids for the Mon\3\88 isolate (Rueda et al., 1991 (Rueda et al., , 1995 Martı! nez et al., 1997) ; (iii) multiple A-G transitions (A-G hypermutations) that are translated into several amino acid changes, some of them involving the loss of one or two cysteines in the conserved cysteine cluster (Rueda et al., 1994 ; Martı! nez et al., 1997) . These results illustrate the capacity of the G glycoprotein to accommodate multiple sequence changes, particularly within the antigenically relevant C-terminal third. A small area of the G gene immediately preceding the part encoding this C-terminal third has been found to be prone to frequent polymerase errors, particularly involving addition or deletion of bases in runs of adenosine residues in mRNA sense, with a proportion of mRNA molecules in infected cells showing the potential to encode G proteins with altered C-terminal regions (Cane et al., 1993) . Some limited use of alternative reading frames and termination codons has also been found among HRSV isolates from patients (Sullender et al., 1991 ; Cane & Pringle, 1995 b) .
Human convalescent sera
Some of the epitopes recognized by human antibodies developed after a natural infection have been mapped in the G protein primary structure by testing the reactivity of convalescent sera either with synthetic peptides (Cane, 1997) or with segments of the G molecule expressed in bacteria as fusion proteins (Cane et al., 1996) . Early analysis, carried out with peptides derived from the HRSV prototype strain A2 (Norrby et al., 1987) , identified peptides from the central conserved region of the G protein only. However, by matching the sequence of the synthetic peptides to that of the infecting genotype of virus, Cane (1997) identified four peptides from the C-terminal third of the G molecule that are recognized by human convalescent sera. Moreover, introduction of amino acid changes found in natural isolates abrogated recognition of the peptides by the human sera. Even with fusion proteins that encompass the variable 84-85 C-terminal residues of the G protein, it was found that the human antibody response was closely related to the infecting genotype (Cane et al., 1996) . The positions of epitopes recognized by human convalescent sera included sequences that are potential N-glycosylation sites that are variable between isolates, indicating an additional mechanism for the masking of antigenic sites from the immune response.
In summary, the G protein C-terminal third contains multiple epitopes that are recognized by both murine monoclonal antibodies and human convalescent sera. Changes in those epitopes can be introduced by single amino acid substitutions or by more drastic changes, including frame-shift mutations or premature stop codons. Thus, it seems that HRSV is well prepared to overcome the pressure of antibodies raised after a natural infection by generating variants with changes in key epitopes of the G molecule.
Evolutionary pattern of the G protein
Variability of HRSV isolates was first demonstrated at the antigenic level in a neutralization test performed with hyperimmune serum (Coates et al., 1966) . Different panels of monoclonal antibodies were later used to subdivide HRSV isolates into two antigenic groups, A and B (Anderson et al., 1985 ; Mufson et al., 1985) , that correlate with genetically distinct viruses (Cristina et al., 1990) . Further studies of HRSV variability have focused mainly in the G protein for two group A HRSV isolates were analysed using the FITCH program from the PHYLIP package, with the tree drawn using DrawTree (Felsenstein, 1993). reasons : (i) the G protein shows the largest antigenic and genetic differences between viruses of the two antigenic groups (Johnson et al., 1987) and (ii) the G protein is one of the targets for the neutralizing and protective antibody response.
Sequence analysis of numerous HRSV isolates, mostly group A, have shown extensive variability of the G glycoprotein (Cane et al., 1991 ; Sullender et al., 1991 ; Garcı! a et al., 1994 ; Cane & Pringle, 1995 b) . Fig. 2 shows the phylogenetic tree derived from 93 partial sequences of the G protein gene of group A viruses. Several features about HRSV evolution emerged from these studies.
(1) Viruses from antigenic group A belong to different lineages that correlate with previously identified genotypes (Cane & Pringle, 1992 ; Garcı! a et al., 1994) . Most epidemics are produced by viruses classified into more than one genotype. At a local level, replacement of predominant genotypes was observed during consecutive years (Cane & Pringle, 1995 a) .
(2) HRSV genotypes have a worldwide distribution and viruses isolated in distant places and in slightly different years may be more closely related than viruses isolated in the same place on two consecutive days (e.g. viruses in clusters 1 and 17 of Fig. 2) .
(3) Within each lineage progressive accumulation of amino acid changes was noted (Cane & Pringle, 1995 b) .
(4) Antigenic changes, detected with a panel of anti-G monoclonal antibodies, correlated with the position of viruses in the phylogenetic tree (Garcı! a et al., 1994 ; Cane & Pringle, 1995 b) .
(5) Whereas synonymous nucleotide changes have a uniform distribution along the G protein gene, non-synonymous changes accumulate preferentially in the two variable regions of the G molecule ( Fig. 1) (Cane et al., 1991 ; Garcı! a et al., 1994) . Fig. 3 shows the ratio (X) of non-synonymous\ synonymous changes for pairs of viruses, represented along the G protein length and with respect to their genetic distances. It can be observed that at certain variable positions the number of non-synonymous changes is up to seven times higher than the number of synonymous changes, indicative of positive selection. Some of the variable sites within the C-terminal third CEBE Review : HRSV G protein Review : HRSV G protein coincide with regions of the G molecule where amino acid changes are selected in escape mutants and in some cases the same amino acid substitutions are observed in escape mutants and natural isolates (Martı! n, 1994) . Preferential accumulation of non-synonymous changes has also been found at the antigenic sites of influenza A virus haemagglutinin (Fitch et al., 1991) , arguing for positive selection of new variants by preexisting antibodies when the virus reinfects the same individual.
Although sequence data for the G protein from HRSV isolates of antigenic group B are much more limited than for group A isolates, the evolutionary pattern of the former and the sequence changes between isolates have the same characteristics as for group A viruses (Sullender et al., 1991) .
Final remarks
The structural and antigenic properties of HRSV G glycoprotein are distinct from the receptor-binding proteins of other members of the family Paramyxoviridae. Fig. 4 shows a model for the three-dimensional structure of the G molecule, modified from the one proposed by Langedijk et al. (1996) . The first hypervariable region, preceding the cysteine cluster, may adopt a rod-like structure due to the addition of multiple Olinked sugar chains (Jentoft, 1990) . This should place the receptor-binding site sufficiently distant from the viral membrane so that it may interact with the cell surface receptor. The structure of the receptor-binding site may be stabilized by two disulphide bridges (cysteines 173-186 and 176-182) , although data from escape mutants that have lost some of the cysteines (Rueda et al., 1994 ; Martı! nez et al., 1997) and peptide analysis (Langedijk et al., 1996) indicate that disulphide bonds are not an absolute requirement for adoption of the appropriate conformation. Recently, the three-dimensional structure of a 19 amino acid segment, included in a 32 residue peptide corresponding to residues 158-189 of the bovine RSV G protein, was elucidated by nuclear magnetic resonance spectroscopy (Doreleijers et al., 1996) . The 19 residue core has a relatively flat surface formed by two short helices connected by a type Ih turn. A characteristic hydrophobic pocket, lined by conserved amino acid residues, lies at the surface of this cystine noose motif and it is a candidate for the receptor binding site.
The second hypervariable region of the G molecule, located after the cluster of cysteines, may be externally located in the homotrimer (Fig. 4) . In this way, it would be more accessible to antibodies and less restricted to genetic changes, such as those selected in escape mutants with premature stop codons or frame-shift mutations. Recent data indicate that glycosylations at the C-terminal end of the G molecule influence the expression of epitopes located near the cluster of cysteines (B. Garcı! a-Beato and others, in preparation). Thus, some flexibility of the C-terminal third may allow interaction with other parts of the G molecule, particularly the other variable region, explaining the apparent compensatory mutations that accumulate in these two segments of the G protein primary structure (Cane & Pringle, 1995 b) .
Although severe HRSV infections occur most frequently during infancy (Glezen et al., 1986) , there is growing evidence that HRSV is an important pathogen for the elderly and the immunocompromised patient (Fleming & Cross, 1993) . Reinfections are thought to be common even in normal adults (Glezen et al., 1986 ; Dowell et al., 1996) . Given the high mutation rate of RNA viruses (Domingo & Holland, 1994) and the capacity of HRSV G glycoprotein to accommodate sequence changes it is possible that pre-existing antibodies select new variants that spread in successive epidemics. Limited published data indeed indicate that reinfections occur more frequently involving viruses of a different antigenic group than the one causing the previous infection (Mufson et al., 1987 ; Waris, 1991) . However, in these studies the viruses were analysed only at the group level and thus the frequency of reinfections by viruses of different genotypes within the same antigenic group is unknown. One added source of antigenic variation may be the human polymorphism for the expression of certain carbohydrate epitopes, such as the Lewis series (Oriol, 1995) . This means that the same HRSV strain infecting different individuals may have different carbohydrate side-chains in the G molecule affecting the expression of certain epitopes, as observed in vitro with certain cell lines (Garcı! a-Beato et al., 1996) .
Despite the extensive genetic and phenotypic differences found in the expression of variable G protein epitopes among HRSV isolates, there are also epitopes in the G protein and in the other surface glycoprotein (F) which are conserved among viral strains. In fact, Power et al. (1997) have demonstrated protective immunity in rodents with a fusion protein expressed in E. coli that contains the central conserved segment of HRSV G glycoprotein. Thus, it may be too naive to claim that antigenic diversity is the only cause of HRSV reinfection. Of course, short-term memory of the post-infection immune response and other factors may also influence the epidemiology of HRSV infections. However, the relative dominance of different epitopes in the humoral immune response during a natural infection is unclear. Early claims that conserved epitopes of the G molecule were recognized preferentially by convalescent sera are complicated by the use of prototype strains rather than viruses matched to the infecting genotype (Cane et al., 1996 ; Cane, 1997) . In addition, the relevance of individual antibodies for the protective immune response remains unclear. Although there is a close correlation between high levels of circulating neutralizing antibodies and protection against HRSV infection, certain neutralizing monoclonal antibodies are not protective when transferred passively to model animals whereas other non-neutralizing antibodies are protective in the same type of assay (Taylor et al., 1984) . The role of the secreted form of the G protein, which carries all the antigenic sites described above, in providing a ' smoke-screen ' against the antibody response also remains to be determined. Further understanding of the relevance of HRSV G protein epitopes in the post-infection antibody response should clarify the role played by antigenic variation in the natural history and epidemiology of this important pathogen.
